China Registry for Genetic / Metabolic Liver Diseases

Summary

CR-GMLD registry started on June 13, 2015 to collect cases of genetic/metabolic liver diseases from tertiary or secondary hospitals in mainland China. Demographics, diagnosis, laboratory test results, family history and prescriptions were recorded. Patients' whole blood and serum were collected for genetic testing and future researches. These patients will be followed-up every six to twelve months.

Conditions

• Genetic/Metabolic Liver Diseases

Interventions

DRUG

Standard of care

Standard of care according to the updated national and/or international guidelines

Sponsors & Collaborators

• Beijing YouAn Hospital

  collaborator OTHER

• Henan Provincial People's Hospital

  collaborator OTHER

• Beijing Ditan Hospital

  collaborator OTHER

• Hebei Medical University Third Hospital

  collaborator OTHER

• Peking University First Hospital

  collaborator OTHER

• Xinjiang Uygur Autonomous Region Traditional Chinese Medicine Hospital

  collaborator UNKNOWN

• Nanfang Hospital, Southern Medical University

  collaborator OTHER

• Logistics University of Chinese People's Armed Police Forces

  collaborator OTHER

• Beijing Anzhen Hospital

  collaborator OTHER

• West China Second University Hospital

  collaborator OTHER

• Jinshan Hospital Fudan University

  collaborator OTHER

• Fudan University

  collaborator OTHER

• Beijing Friendship Hospital

  lead OTHER

Principal Investigators

• Jidong Jia, Doctor · Beijing Friendship Hospital

Eligibility

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2015-06-13

Primary Completion

2022-04-28

Completion

2027-04-28

Countries

• China

Study Locations